Regulatory News for May 2016

Incentives to tackle antimicrobial resistance will help, but patent filing data indicates that research to find new antibiotics is still very much on big pharma’s agenda, says Withers & Rogers Incentives to tackle antimicrobial resistance will help, but patent filing data indicates that research to find new antibiotics is still very much on big pharma’s agenda, says Withers & Rogers

A UK Government review warning of an ‘antibiotics apocalypse’ is recommending the introduction of incentives to encourage pharmaceutical companies to invest in research activity to find new drugs and treatments to tackle antimicrobial resistance.
27 May, 2016